PBYI
PBYI
NASDAQ · Biotechnology

Puma Biotechnology Inc

$9.59
-0.01 (-0.10%)
As of Sep 21, 3:26 PM ET ·
Analyst Consensus
Strong Sell
6
Analysts
Moderate
Coverage
Buy 0 0%
Hold 3 50%
Sell 3 50%
Price Target
Analyst Price Target -43.2% upside
Low Target $2.99
Average Target $5.45
High Target $6.80
Current Price $9.59
Current
$9.59
Target
$5.45
$2.99 $5.45 avg $6.80
Scenario Analysis
Bear Case
$2.99
-68.8%
Low target
Base Case
$5.45
-43.2%
Avg target
Bull Case
$6.80
+-29.1%
High target
Risk/Reward
0.4x
Unfavorable
Price in Context
52-Week High
$9.74
-1.5% from high
52-Week Low
$4.30
+123.0% from low
Target vs 52W High
$5.45
-44.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.9%
AMGN
Amgen Inc
Hold 43 47% $190.87 -53.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +137.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.9%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -18.1%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -63.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%